2020
DOI: 10.1016/j.jacr.2020.09.001
|View full text |Cite
|
Sign up to set email alerts
|

ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
31
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 25 publications
(36 citation statements)
references
References 88 publications
0
31
0
Order By: Relevance
“…Despite its relatively high prevalence, the overall prognosis of EC is favorable with a worldwide low mortality rate estimated at 2.4% [2,3,7]. Approximately 82% of EC are diagnosed at an early stage of the disease, with abnormal vaginal bleeding or discharge being the initial symptom, which contributes to its global good prognosis [4].…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…Despite its relatively high prevalence, the overall prognosis of EC is favorable with a worldwide low mortality rate estimated at 2.4% [2,3,7]. Approximately 82% of EC are diagnosed at an early stage of the disease, with abnormal vaginal bleeding or discharge being the initial symptom, which contributes to its global good prognosis [4].…”
Section: Introductionmentioning
confidence: 99%
“…The type II or estrogen-independent carcinomas account for 10% to 20% of EC and are composed of grade 3 endometrioid carcinoma and all non-endometrioid tumors. This type of tumor is less hormone-sensitive and generally more aggressive with a poorer prognosis than type I [6,[7][8][9].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations